| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjusting Overall Survival Estimates after Treatment Switching: a Case Study in Metastatic Castration-Resistant Prostate Cancer
|
Skaltsa, Konstantina
|
|
2016
|
12 |
1 |
p. 111-121
|
article
|
| 2 |
Effect of Targeting Clusterin Using OGX-011 on Antitumor Activity of Temsirolimus in a Human Renal Cell Carcinoma Model
|
Nishikawa, Masatomo
|
|
2016
|
12 |
1 |
p. 69-79
|
article
|
| 3 |
Erratum to: Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)
|
Scartozzi, Mario
|
|
2016
|
12 |
1 |
p. 123
|
article
|
| 4 |
Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma
|
Di Costanzo, Giovan Giuseppe
|
|
2016
|
12 |
1 |
p. 61-67
|
article
|
| 5 |
Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma
|
Di Costanzo, Giovan Giuseppe
|
|
|
12 |
1 |
p. 61-67
|
article
|
| 6 |
mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review
|
Statz, Cara M.
|
|
2016
|
12 |
1 |
p. 47-59
|
article
|
| 7 |
New Biomarkers for Selecting the Best Therapy Regimens in Metastatic Castration-Resistant Prostate Cancer
|
Heidegger, Isabel
|
|
2016
|
12 |
1 |
p. 37-45
|
article
|
| 8 |
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer
|
Laethem, Jean-Luc Van
|
|
2016
|
12 |
1 |
p. 97-109
|
article
|
| 9 |
Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry
|
Kopeckova, Katerina
|
|
2016
|
12 |
1 |
p. 89-95
|
article
|
| 10 |
Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action
|
Duran, I.
|
|
2016
|
12 |
1 |
p. 19-35
|
article
|
| 11 |
Response to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma with the Rare Epidermal Growth Factor Receptor Mutation S768I: a Retrospective Analysis and Literature Review
|
Zhu, Xiaoli
|
|
2016
|
12 |
1 |
p. 81-88
|
article
|
| 12 |
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma
|
Swamy, Supritha G.
|
|
2016
|
12 |
1 |
p. 1-10
|
article
|
| 13 |
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma
|
Swamy, Supritha G.
|
|
|
12 |
1 |
p. 1-10
|
article
|
| 14 |
The Unexpected Roles of Aurora A Kinase in Gliobastoma Recurrences
|
Willems, Estelle
|
|
2016
|
12 |
1 |
p. 11-18
|
article
|
Journal description